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Abstract
Background: Testis-sparing surgery is not popular in South China. This study aimed to investigate this procedure
for pediatric testicular tumors.
Methods: Children with testicular benign tumors were retrospectively analyzed from January 2001 to June 2015 in
the Sun Yat-sen University Cancer Center (SYSUCC) and the First Affiliated Hospital (SYSU-1st). Follow-up was performed
until June 2016, and the proportions of TSS in the two hospitals during the different periods were compared.
Results: Forty-seven children with testicular benign tumors were enrolled, and 16 cases underwent testis-sparing
surgery. All patients were cured and discharged, which included mature teratoma (n = 37), testicular adrenal rest tumors
(n = 4), epidermal cysts (n = 3), granulomatous inflammation (n = 2) and adenomatoid tumors (n = 1). Inguinal
testis-sparing surgery was performed in 16 children, and no recurrence was detected during follow-up. It was
performed more frequently in SYSUCC than in SYSU-1st (P = 0.031), and the tumor size of these patients was
smaller than those of patients who underwent radical orchiectomy (P = 0.044). Moreover, testis-sparing surgery has
become more common in the past 5 years, although differences over time have not reached significance (P = 0.051).
Conclusions: Testis-sparing surgery is reliable, and tumor size and special hospitals affect its success. Additionally, its
use has become more popular in recent years. However, advocacy is still needed for the use of this technique in
pediatric testicular benign tumors that are small sized.
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Background
Testicular tumors are one of the most common solid
tumors in children, but their incidence is as low as 0.5–
2.0/100 000 [1–4]. Because of their rarity, they are often
overlooked during clinical management and treated as
to their adult counterparts [5, 6]. Recent studies have
found that there are significant differences between tes-
ticular tumors in children and adults [7–9]. Especially,
the proportion of benign testicular tumors in children
is significantly higher than that in adults, which should
affect to the evolution of the diagnosis and treatment
for pediatric testicular tumors [2, 10, 11]. In recent
years, it has been reported that testis-sparing surgery
(TSS) could control pediatric testicular benign tumors
effectively and retain the normal tissue of the testis
[12–15]. However, the role of TSS is controversial, and
indications and feasibility are uncertain. In this study, a
retrospective analysis was performed to investigate the
outcome and trend of TSS for testicular benign tumors
of children in two high-volume centers.
The Sun Yat-sen University Cancer Center (SYSUCC)
and the First Affiliated Hospital (SYSU-1st) are two
high-volume medical centers in South China. Due to
their high standing status, this report might be a fair
representation of pediatric testicular benign tumors in
South China.
Methods
The data of patients with testicular tumors from January
2001 to June 2015 were retrospectively analyzed.
Patients aged >12 years and those with non-primary
lesions were excluded. The pathology reports were re-
trieved by an experienced pathologist (Liao), and benign
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tumors were screened. Clinical data including age, presen-
tation, serum markers (alpha fetoprotein, AFP; human
chorionic gonadotropin, HCG; lactate dehydrogenase,
LDH), images, management and follow-up were recorded.
For boys with normal serum markers or other charac-
ters of a benign tumor, testis-sparing surgery was taken
into consideration. With informed consent, after dissect-
ing the tumor en bloc through an inguinal incision, an
intra-operative biopsy was performed. If no malignant
tumor was detected, testis-sparing surgery was per-
formed, or a radical orchiectomy was performed.
Close follow-up was required for all patients every 3–
6 months for 1 year and then annually, including the
general condition, growth and development, recent
physical examination, and scrotum and/or retroperiton-
eal ultrasonography.
Using the SPSS 21.0 Package, the proportions of
testis-sparing surgery in the two hospitals during differ-
ent periods were compared with a χ2 test and rank sum
test. P < 0.05 was considered to be significant.
Results
From January 2001 to June 2015, a total of 47 children
with benign testicular tumors were treated in the two
hospitals, including 16 cases that underwent testis-
sparing surgery. The patients were aged from 3 months
to 141 months, with a median age of 38 months. There
were 21 cases on the left side, 22 cases on the right side,
and 4 cases that were bilateral; the latter were all testicu-
lar adrenal rest tumors. The maximum diameter of
tumors ranged from 0.3 cm to 5.4 cm, and the median
size was 2.5 cm. The preoperative level of serum AFP
was 9.30–138.2 μg/L (normal range: 0.00–25.00 μg/L),
and 6 patients aged 4–14 months had elevated AFP, with
a median level of 56.0 μg/L (range from 30.3–138.2 μg/L).
Elevated levels of HCG and LDH were not detected.
The numbers of mature teratomas, testicular adrenal
rest tumors, epidermal cysts, granulomatous inflamma-
tion and adenomatoid tumors were 37, 4, 3, 2 and 1, re-
spectively, and all patients were cured and discharged.
Inguinal testis-sparing surgery was performed on 16
children, including 8 with mature teratomas, 4 with tes-
ticular adrenal rest tumors, 3 with epidermal cysts and 1
with an adenomatoid tumor. Radical orchiectomy was
performed in 27 children who were referred to these
two centers, and the other 4 orchiectomies were per-
formed in basic hospitals, including 2 who received a
scrotal orchiectomy (comparisons between the two
groups are shown in Table 1). Of these 31 patients, 29
had teratoma and 2 had granulomatous inflammation.
During the operation, 21 frozen section examinations
(FSEs) were performed, and 18 were benign disease.
Sixteen patients underwent testis-sparing surgery, and
the other two were suspended for mini-residual normal
tissues (<1.0 cm). For patients who underwent testis-
sparing surgery, the maximum diameter of the tumors
ranged from 0.3 cm to 2.4 cm, and the median size was
1.6 cm, which was smaller than in those who underwent
orchiectomy (P = 0.044). One child with an epidermal
cyst had an AFP level of 76.2 μg/L. Only 4 children with
testicular adrenal rest tumors and 1 with a mature tera-
toma underwent TSS before 2010 (24 children in all),
which was lower than in the most recent 5 years (P =
0.051). The proportion of TSS was 12/25 in the cancer
center, which was higher than the proportion in the gen-
eral hospital (12/25 vs. 4/22, P = 0.031) (as shown in
Table 1).
Until June 2016, only 28 cases were still actively
followed in the hospital, including 15 patients who
underwent TSS, and the remaining patients were
followed up with by telephone. One patient was lost
after follow up of 7 months. The median follow-up time
was 56 months, with a range from 11 months to 147
months. No patient had complications, such as tumor
recurrence, metastasis or testicular atrophy, and there
were 3 cases of natural fertility.
Discussion
During January 2001 to June 2015, 171 children with
testicular tumors were treated in our two affiliated hos-
pitals, and the proportions of benign tumors and tera-
toma were 27% and 22%, respectively, which were lower
than the proportions reported in Europe and the United
States (74% and 48%, respectively) but close to those in
South Korea (47% and 39%, respectively) [2, 4, 10],
which might be due to geographical factors. For their
benign biological behavior, testis-sparing surgery was
performed in these patients. Initially, testicular benign
tumors with a size of 2–3 cm were a candidate for TSS,
so preoperative evaluation was the basis for this proced-
ure [16, 17].
Testicular tumor markers and ultrasound are two
important tools in the evaluation of pediatric testicular
tumors. Because yolk sac tumors are the most common
Table 1 Characteristics of children underwent Testis-sparing
surgery and Radical orchiectomy
TSS (16) RO (31) P
Age (years) 5.5 (0.3–12) 2.1 (0.4–12) 0.238
Size (cm) 1.6 (0.3–2.4) 2.7 (1.3–8.0) 0.044
AFP (elevated proportion) 1/16 5/31 0.648
Period
(after 2010 before 2010) 11 5 12 19 0.051
Hospital
(SYSUCC: SYSU-1st) 12 4 13 18 0.031
TSS testis-sparing surgery
RO radical orchiectomy
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malignant germ cell tumors in children, and AFP is
elevated in >90% of pediatric yolk sac tumors, it is im-
portant to note that serum AFP levels in infants are nor-
mally higher than those in adults and reduce to normal
levels by the age of 1. Therefore, for children <1 year old
with testicular tumors, an elevated AFP level could be
detected in those with benign tumors. On the other
hand, for children >1 year, a normal level of AFP often
indicates a benign tumor. Additionally, ultrasound could
help distinguish the tumor origin and type, and it can
play a role in evaluating normal tissues for testis-sparing
candidates [18]. In this study, elevated AFP was detected
in 6 children, and 5 of them underwent radical orchiec-
tomy, while the other one had typical ultrasound charac-
teristics of an epidermal cyst. Although boys with an
elevated AFP level were inclined to have a malignant
tumor and undergo radical orchiectomy, no significance
was detected in this study. Therefore, for boys less than
1 year old, an elevated level of AFP was not indicative of
a malignant tumor. Combined with well circumscribed
ultrasound characteristics and decreased blood flow, a
benign tumor should be taken into consideration. Add-
itionally, during the operation, ultrasound could help to
mark the tumor location when it was nonpalpable [19].
Other imaging, such as CT or MRI, was suggested to de-
termine the stage when suspicion of malignancy was
presented [20].
Generally, testicular tumors with a size <2.5 cm in
diameter are defined as small testicular masses, and
testis-sparing surgery has increasingly been performed
for these lesions [21]. Additionally, masses with a diam-
eter <2 cm were considered to be good candidates for
TSS because nearly 80% of these cases were benign [22,
23]. In this study, tumor size ranged from 0.3 cm to 2.4
cm, and 2 cases of TSS were suspended due to scant re-
sidual normal tissues. The size of the TSS group was
smaller than that of the radical orchiectomy group, and
this might be related to the smaller size associated with
a high proportion of benign tumors and difficulty of sav-
ing normal testicular tissues in larger size tumors.
Testis-sparing surgery is becoming increasingly more
common for the treatment of pediatric testicular tumors,
and long-term outcomes are favorable, although the
number of reported cases is still small (11–21 cases) [14,
19, 24, 25]. For preoperative evaluation, including ultra-
sonography and serum markers, an FSE was critical to
this procedure, and tumors with benign characteristics
and size <2 cm were indicated. In this study, detailed
examination and consultation were performed preopera-
tively, and an FSE was performed by dedicated patholo-
gists. Testis-sparing surgery was more common in
SYSUCC, which might be due to the unpopularity of
testis-sparing surgery in South China. Although testis-
sparing surgery has been performed more frequently in
recent years, this was not statistically significant. Few
testis-sparing surgeries were accomplished in general
hospitals, including SYSU-1st and other basic hospitals.
Maybe this was because it was not totally accepted by
the urologists.
At present, a combination of preoperative evaluation
and intra-operative biopsy could help urologists distin-
guish testicular benign tumors and malignant tumors
effectively [22]. In fact, it was feasible and reliable in this
study as well as in recent reports, and no recurrence or
atrophy was recorded [5, 25]. Moreover, preservation of
the testis could reduce the physiological and psycho-
logical impact on patients [24]. Therefore, a careful pre-
operative evaluation of pediatric testicular tumors,
including scrotal ultrasound and serum markers, should
be taken into consideration, and testis-sparing surgery
should be offered to children with benign tumors if pos-
sible. In our opinion, the tumor size (<2.5 cm) and the
volume of residual normal tissues (>1.0 cm) were
important indicators for this procedure.
Though our series was not large and it was retro-
spectively analyzed, it presents a profile of testis-
sparing surgery in South China, and we suggest and
advocate testis-sparing surgery for pediatric testicular
benign tumors.
Conclusions
Benign testicular tumors in children are not rare, and
testis-sparing surgery is reliable. Tumor size and special
hospitals affect the success of TSS and it should be ad-
vocated for the treatment of pediatric testicular tumors.
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